Medpace Voice

As innovation accelerates across diabetes and endocrinology – particularly in areas like type 1 and type 2 diabetes, cell and...

With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development...

Radiopharmaceuticals are reshaping oncology trials through integrated imaging, dosimetry, and therapeutic precision. Following SNMMI, Medpace experts share considerations for biopharma Sponsors navigating the scientific, operational,…

Breast cancer persists as a critical global health challenge, with an estimated 1 in 8 women facing a diagnosis over...

The evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH) research demands precise and reliable methodologies to ensure accurate data collection and...

[New Webinar] In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women…

Watch this on-demand presentation about imaging data quality and how the advancements in AI and machine learning help track the quality of images, assess issues…

Our experts explore the medical, operational, imaging, and regulatory considerations for radiopharmaceutical dosimetry.

In this new whitepaper, experts from Medpace and Medidata discuss the recent advances in artificial intelligence and machine learning and the benefits of using this technology…

This brand new infographic explores the different types of imaging techniques, their advantages, limitations, and how they can be successfully implemented in clinical trials.